Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
LetiGranada is a topical veterinary skincare product line developed by LETI Pharma Animal Health as part of their LETI+Derma dermatological range. The product's primary active ingredients are bioactive polyphenols extracted from pomegranate (*Punica granatum*), which provide potent antioxidant and antimicrobial properties. It is specifically formulated for the management and hygiene of sensitive or irritated skin in companion animals, particularly dogs and cats suffering from conditions such as atopic dermatitis. Available in multiple formulations including shampoos and creams, LetiGranada works by supporting the skin barrier and neutralizing oxidative stress, thereby helping to manage the clinical signs of dermatological disorders in a non-pharmaceutical, over-the-counter capacity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on LetiGranada.